Share chart Apollomics, Inc.
Extended chart
Simple chart
About Apollomics, Inc.
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. more details| IPO date | 2021-11-26 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Цена ао | 0.026 |
| Change price per day: | -68.85% (0.026) |
|---|---|
| Change price per week: | -68.85% (0.026) |
| Change price per month: | -68.85% (0.026) |
| Change price per 3 month: | -68.85% (0.026) |
| Change price per half year: | -68.85% (0.026) |
| Change price per year: | -72.91% (0.0299) |
| Change price per year to date: | -68.85% (0.026) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Ehp Funds Inc. | 498450 | 4.82 |
| Warberg Asset Management LLC | 445600 | 4.31 |
| Walleye Capital LLC | 383744 | 3.71 |
| BOOTHBAY FUND MANAGEMENT, LLC | 373715 | 3.61 |
| Yakira Capital Management, Inc. | 362364 | 3.5 |
| Shaw D.E. & Co., Inc. | 318530 | 3.08 |
| Context Capital Management, LLC | 298500 | 2.88 |
| MMCAP International, Inc. SPC | 250000 | 2.42 |
| Walleye Trading LLC | 215856 | 2.09 |
| Whitebox Advisors, LLC | 200000 | 1.93 |
